Stay updated with breaking news from Wuhans Only. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Growing body of clinical evidence supports transformational potential of Vaxart’s oral vaccine platform Clinical trial programs on track for reporting key data milestones Ended third quarter... | November 8, 2022
(RTTNews) - Vaxart, Inc. (VXRT) reported positive top-line data from the first part of a planned two-part phase II study of its Wuhan S-only oral ...
Top-line data from COVID-19 Phase II study expected in the third quarter of 2022 Vaxart initiates work on vaccine candidates that directly target new...